Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases

Saeedeh Ghorbanalipoor¹, Shirin Emtenani¹, Melissa Parker², Mayumi Kamaguchi¹, Colin Osterloh¹, Manuela Pigors¹, Natalie Gross¹, Stanislav Khil'chenko¹, Anika Kasprick¹, Sabrina Patzelt¹, Diana Wortmann¹, Ibrahim O Ibrahim¹, Kentaro Izumi¹, Stephanie Goletz¹, Katharina Boch³, Kathrin Kalies⁴, Katja Bieber¹, Paul Smith², Enno Schmidt¹, Ralf J Ludwig¹

Affiliations

¹ Lübeck Institute of Experimental Dermatology and Center for Research on Inflammation of the Skin, University of Lübeck, Lübeck, Germany.
² Incyte Research Institute, Wilmington, DE, United States.
³ Department of Dermatology, University of Lübeck, Lübeck, Germany.
⁴ Institute of Anatomy, University of Lübeck, Lübeck, Germany.

PMID: 36532003
PMCID: PMC9748735
DOI: 10.3389/fimmu.2022.1099535

Published Erratum

Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases

Saeedeh Ghorbanalipoor et al. Front Immunol. 2022.

. 2022 Nov 30:13:1099535.

doi: 10.3389/fimmu.2022.1099535. eCollection 2022.

Authors

Affiliations

¹ Lübeck Institute of Experimental Dermatology and Center for Research on Inflammation of the Skin, University of Lübeck, Lübeck, Germany.
² Incyte Research Institute, Wilmington, DE, United States.
³ Department of Dermatology, University of Lübeck, Lübeck, Germany.
⁴ Institute of Anatomy, University of Lübeck, Lübeck, Germany.

PMID: 36532003
PMCID: PMC9748735
DOI: 10.3389/fimmu.2022.1099535

Abstract

[This corrects the article DOI: 10.3389/fimmu.2022.865241.].

Keywords: animal model; autoimmunity; epidermolysis bullosa acquisita; mucous membrane pemphigoid; neutrophils; pemphigoid; phosphatidylinositol 3-kinase (P13k); signal transduction.

Copyright © 2022 Ghorbanalipoor, Emtenani, Parker, Kamaguchi, Osterloh, Pigors, Gross, Khil’chenko, Kasprick, Patzelt, Wortmann, Ibrahim, Izumi, Goletz, Boch, Kalies, Bieber, Smith, Schmidt and Ludwig.

PubMed Disclaimer

Erratum for

Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases.
Ghorbanalipoor S, Emtenani S, Parker M, Kamaguchi M, Osterloh C, Pigors M, Gross N, Khil'chenko S, Kasprick A, Patzelt S, Wortmann D, Ibrahim IO, Izumi K, Goletz S, Boch K, Kalies K, Bieber K, Smith P, Schmidt E, Ludwig RJ. Ghorbanalipoor S, et al. Front Immunol. 2022 Sep 28;13:865241. doi: 10.3389/fimmu.2022.865241. eCollection 2022. Front Immunol. 2022. PMID: 36248903 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases

Affiliations

Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases

Authors

Affiliations

Abstract

Erratum for

Publication types

LinkOut - more resources

Full Text Sources